reSee.it - Related Video Feed

There are concerns about the long-term side effects of modifying DNA and RNA to enable the production of antibodies. The potential for causing mutations or other risks in the future is uncertain.

The speaker expresses caution regarding the long-term side effects of modifying people's DNA and RNA. They state there is a risk associated with directly encoding the ability to produce antibodies into a person's DNA and RNA. The speaker is concerned about potential mutations or other downstream risks.

"Packaged DNA fragments have been found en masse as vaccine contaminants." "Once they reach the nucleus, short DNA sequences have an increased propensity to insert into chromosomal DNA." "The possible consequences are unending." "Disruption of the exquisitely tuned network that controls cell division and differentiation can lead to cancer and to developmental defects." "Mutations in sperm and fertilized egg cells could render altered traits inheritable." "Cost effective procedures to reliably separate mass produced RNA from plasmids do not exist." "Contamination of RNA vaccines with plasmid DNA must therefore be expected to be the rule and not the exception." "Whoever propagates RNA vaccines as being safe and effective, whoever claims that nothing can happen to your genome, is either incredibly ignorant or endlessly evil."

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

Integrating foreign genes into chromosomes can lead to cancer and other health issues, permanently altering genetics and affecting future generations. This is a call to recognize the dangers posed by RNA vaccines being introduced globally by organizations like the WHO, CDC, and FDA. The initial vaccines have already shown harmful effects due to the introduction of foreign genes into the body. The production of mRNA does not ensure that these genes, often derived from bacteria, won't enter human cells. As a result, individuals receiving these vaccines may experience genetic alterations, and any genetically altered cell is at risk.

We are currently injecting large amounts of DNA into billions of people, which may affect germ lines, stem cells, sperm, and eggs. The number of DNA injections is in the range of 50-100 billion, and if 1% reaches the ovaries, it could potentially impact around 40-400 million oocytes. This experimental use of poorly characterized tools with liability protection is a significant departure from previous biomedical ethics standards. These genomic changes in the germ line can be passed down to future generations, and if it affects stem cells, it may lead to cancer. This practice is concerning and needs to be questioned.

The Pfizer and Moderna vaccines contain fragments of DNA, which can integrate into the genomic DNA of cells and become a permanent part of the cell. This poses a potential risk of autoimmune attacks and future cancer. The DNA contamination occurred during the production process, where a plasmid vector was used to scale up the production of the RNA template. The regulatory threshold for DNA in vaccines is outdated and not suitable for this new type of vaccine. The speaker believes that DNA sequencing should be done on vaccinated individuals' stem cells to determine if this theoretical risk has occurred. Informed consent is necessary, and the lack of transparency regarding the DNA contamination is concerning.

The mRNA in vaccines can replicate, including the replication engine, leading to potential spread from person to person. Concerns exist about the inability to stop this replication, with unknown consequences for humanity. The spike protein in these vaccines can be toxic, affecting various tissues. Deployment of this technology in vaccines for humans is already happening, with over 4,000 people injected in Japan.

I have concerns about modifying DNA and RNA to encode antibodies directly, as the long-term effects are unknown. There may be risks like mutations or other issues in the future.

The speaker expresses caution regarding the long-term side effects of modifying people's DNA and RNA. They state there are unknown risks associated with directly encoding the ability to produce antibodies into a person's DNA and RNA. The speaker is concerned about the potential for mutations or other downstream risks.

The introduction of foreign genes into human chromosomes can lead to immediate cancer and inflammation, and these changes can be passed on to future generations. This is a serious warning about the dangers posed by RNA vaccines being introduced globally by organizations like the WHO, CDC, and FDA. The first vaccines have already been released, and they are causing significant harm by introducing foreign genes into the body. The production of mRNA does not ensure that these bacterial genes will not enter human cells, resulting in genetic alterations. Any cell that undergoes such genetic changes is at risk.

Some medicines may have side effects, so safety testing is necessary. This includes genetically modified organisms that are injected into children's arms directly into the vein.

A study from Lund University in Sweden indicates the Pfizer vaccine can reverse transcribe and install DNA into the human genome within a human liver cell line. This suggests an enzyme can transfer messenger RNA vaccine information into a person's DNA, a process previously claimed impossible. This finding potentially opens the door to lawsuits regarding genetic discrimination (GINA) against individuals who chose not to receive the vaccine. It raises concerns about potential impacts on the DNA of those vaccinated, including pregnant women and their babies. The CDC states that the vaccine will not change a person's DNA, but this new paper suggests otherwise.

The Pfizer vaccine may contain DNA in addition to mRNA, according to a scientist who sequenced the vaccine in his lab. He obtained empty vials from a colleague and found DNA in them. This DNA could potentially cause serious side effects and integrate into the genomic DNA of cells, leading to long-term effects. The scientist is concerned about the regulatory process that allowed this to happen and warns of the risks of genome modification and autoimmune attacks. While the risk of cancer is believed to be rare, it is not zero. Further investigation is needed to determine the extent of these risks.

The speaker cautions that we don’t know the long-term side effects of modifying people’s DNA and RNA to directly encode the ability to produce antibodies, and whether that causes other mutations or downstream risks.

Alden and colleagues found that Pfizer's genetic code can be integrated into the human genome within an hour in a cancerous cell line. This suggests that Pfizer and Moderna's genetic material might become a permanent part of human DNA. There is no study confirming or denying this possibility. The concern is that if eggs or sperm incorporate this genetic code, it could be passed on to future generations. This lack of research is seen as reckless and worrisome.

The Pfizer vaccine contains not only mRNA but also plasma DNA from the vector used in its production. I sequenced samples from two batches of the vaccine in Colombia and found this DNA, which raises concerns about potential health risks. This DNA could integrate into the genomic DNA of cells, leading to permanent changes. Such integration poses theoretical risks, including autoimmune responses and cancer, depending on where the DNA inserts itself in the genome. While these risks may be rare, they warrant investigation to understand their implications better.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

Speaker 0 cautions about the long-term side effects of directly modifying a person’s DNA and RNA to encode antibodies. They raise concerns that such genetic or molecular modifications could lead to unforeseen consequences over time, including potential mutations or other risks that might arise downstream as a result of encoding these antibodies.

The safety of messenger RNA (mRNA) vaccines, such as Pfizer and Moderna, is being questioned. Studies have shown that mRNA can be toxic to heart muscle cells and can remain in the human heart, bloodstream, lymph nodes, and injection site for extended periods. This raises concerns about the safety of mRNA technology for vaccines, as it may make flu shots and other vaccines more dangerous. Some argue for a ban on mRNA development due to the COVID-19 vaccine controversy.

The Pfizer vaccine may contain DNA in addition to mRNA, according to a researcher who sequenced the vaccine in their lab. The DNA is a vector used in the production of the mRNA. The researcher expressed concern about the potential consequences of this, including rare but serious side effects like death from cardiac arrest. The DNA could integrate into the genomic DNA of cells and become a permanent part of them, posing a risk of genome modification and autoimmune attacks. There is also a theoretical risk of future cancer depending on where the foreign DNA lands in the genome. The researcher believes further investigation is needed to determine if these risks are occurring.

The Pfizer vaccine is contaminated with plasma DNA, not just mRNA. This DNA is the DNA vector used as the template for the in vitro transcription reaction. This was discovered by sequencing vials of Pfizer vaccine from Colombia. It's surprising that there's any DNA in there. The speaker is alarmed about the possible consequences of this, including rare but serious side effects like death from cardiac arrest. Mixing DNA with a lipid complex allows it to enter cells and become a permanent fixture. This is a real hazard for genome modification of long-lived somatic cells, like stem cells, and could cause a sustained autoimmune attack. There is also a very real theoretical risk of future cancer in some people. The risk is not zero and it may be high enough that we ought to figure out if this is happening or not.

Are there concerns regarding the side effects of medicines? Is safety testing necessary? We are administering genetically modified organisms through injections, particularly in young children.

I have concerns about modifying DNA and RNA to encode antibodies directly, as we don't know the long-term effects. There may be risks like mutations or other issues in the future.

Caution about long-term side effects of modifying people’s DNA and RNA to directly encode the ability to produce antibodies, and whether this could cause other mutations or downstream risks.